OpenAI & Retro Bio accelerate protein engineering with GPT-4b micro

AI Impact Summary

OpenAI and Retro Bio are leveraging GPT-4b micro to accelerate protein engineering for applications in stem cell therapy and longevity research. This model’s specialized training allows for rapid iteration and optimization of protein sequences, potentially leading to faster development of novel therapeutics and a deeper understanding of biological processes. The collaboration highlights the growing trend of AI-driven discovery in complex scientific domains, demanding a shift in traditional research methodologies.